Bioactive Glass (Sol-gel) for Alveolar Bone Regeneration After Surgical

Status Completed

Clinical Trial Summary

The purpose of the present research is to evaluate the effect of bioactive glass in bone regeneration immediately following extraction of mandibular and maxillary premolars.The hypothesis of the study assumes that this treatment would promote the healing of the extraction socket while preserving both the height and width of the bone. Furthermore, it would allow more effective tooth movement during orthodontic treatment.

Clinical Trial Description

Bioactive glass has long been known as a bone graft substitute capable of bone augmentation. The current proposal introduces a newly tailored bioactive glass scaffold with multi-scale porosity prepared using the sol-gel technique to regenerate bone in extraction sockets with the aim of preserving the alveolar ridge. This novel material has the potential to enhance angiogenesis and osteogenesis thereby preserving the overall height and width of the alveolar bone by regenerating new bone that closely mimics the adjacent healthy one. Thirty patients requiring myofunctional therapy including premolar extraction as part of a two stage orthodontic treatment (class II division I) will be enrolled in this phase I/II clinical study. Patients will undergo extraction of their maxillary and mandibular premolar teeth. This will serve as a split-mouth study where on one side the extraction sockets will be left empty while on the other side they will receive the bioactive glass as a bone graft substitute. Clinical and radiographic assessment of healing will be performed at the following time intervals; 1,2,4,12,24 weeks. Clinical criteria will include scoring for pain, inflammation, and occurrence of any post-operative complications using a well-defined scoring system. Radiographic assessment will monitor the changes in crestal bone height and bone mineral density. Computed tomographic scans will also be taken preoperatively and at 6 months for each patient for 3D assessment of bone changes. A core biopsy will also be taken after informed consent at the 6 months time-point to evaluate the quality and quantity of new bone formed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01878084
Study type	Interventional
Source	Alexandria University
Contact
Status	Completed
Phase	N/A
Start date	October 2013
Completion date	January 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04043286` - The Effects of Dis/Reconnection of Implant Abutments on Peri-implant Bone Levels	N/A
Recruiting	`NCT03046147` - The Effect of Roux-en-Y Gastric Bypass on Bone Turnover	N/A
Completed	`NCT01292395` - Effects of Dietary Protein on Musculoskeletal Health During Calorie Deficiency	N/A
Completed	`NCT00485953` - Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy	Phase 4
Completed	`NCT00674453` - The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation	Phase 2
Completed	`NCT00181584` - Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer	Phase 2
Withdrawn	`NCT04380155` - Cycling Duration and Bone Markers in in Active Young Adults	N/A
Active, not recruiting	`NCT04779216` - Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa	Phase 3
Completed	`NCT05371418` - Comparative Clinical and Radiographical Evaluation of Treatment of Angular Bone Defect Related to Over Erupted Tooth Using GTR Followed by Orthodontic Intrusion Versus Orthodontic Intrusion Followed by GTR	N/A
Not yet recruiting	`NCT04345250` - Bone Response to Exercise and Energy Restriction in Young Adults	N/A
Recruiting	`NCT05405894` - Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Active, not recruiting	`NCT05301400` - Marginal Bone Loss in Single Implant Restaurations With Different Methods	N/A
Recruiting	`NCT04983758` - 20-year Implant Survival in Periodontally Healthy and Compromised Patients
Recruiting	`NCT04713774` - Bone Density and Vascular Calcifications Evolution After Renal Transplant
Completed	`NCT04279392` - Healthy Body, Healthy Bones After Bariatric Surgery Trial	Phase 1/Phase 2
Completed	`NCT04332679` - Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes	N/A
Completed	`NCT05721014` - Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health	N/A
Recruiting	`NCT04883502` - Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs
Not yet recruiting	`NCT05066815` - Evaluation of Crestal Bone Loss Around Short Dental Implants As Affected By Two Suprastructure Materials	N/A
Completed	`NCT03292146` - Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Bioactive Glass (Sol-gel) for Alveolar Bone Regeneration After Surgical Extraction

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms